EMGenisys

About:

EMGenisys offers an embryo health assessment platform that determines embryo viability and sex in a single assessment in the lab.

Website: https://www.emgenisys.co

Twitter/X: EMGenisys

Top Investors: Luminate, Texas A&M Innovation

Description:

EMGenisys offers an embryo health assessment platform that determines embryo viability and sex in a single assessment in the lab. Its technology utilizes video motion magnification to determine if cells are actively dividing or decaying, ensuring the embryos are alive and healthy at the time of transfer. It aims to improve animal production to further sustainability and promote animal welfare through advancements in reproductive technologies.

Total Funding Amount:

$630000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2019-01-01

Founders:

Cara Wells, Russell Killingsworth

Number of Employees:

1-10

Last Funding Date:

2024-10-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai